TURNSTONE BIOLOGICS CORP.

Press Releases Turnstone Biologics Corp.

Equities

TSBX

US90042W1009

Market Closed - Nasdaq Other stock markets 01:30:00 25/05/2024 am IST			5-day change	1st Jan Change
2.6 ^USD	+0.78%		-2.26%	+2.16%

13/05	Turnstone Biologics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
16/04	Turnstone Biologics Corp. Announces Board Changes	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights	14/05	GL
Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference	08/05	GL
Turnstone Biologics Appoints William Waddill to its Board of Directors	16/04	GL
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights	22/03	GL
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights	22/03	AQ
Turnstone Biologics to Participate in Upcoming Investor Conferences	21/02	AQ
Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.	21/02	GL
Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference	27/11	GL
Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights	10/11	GL
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting	03/11	GL
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting	03/11	AQ
Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber	30/23/30	GL
Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting	28/23/28	GL
Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting	28/23/28	AQ
Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update	02/23/02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer